CasNo.441045-17-6,favourable ?price of 441045-17-6 High quality in bulk price,(441045-17-6) Suppliers

1 Metric Ton	Negotiable

Min.Order :1 Metric Ton
Purity: 99%
Payment Terms : T/T,

Keywords

High quality 441045-17-6 favourable ?price of 441045-17-6 Eribulin Mesylate in bulk price

Quick Details

Appearance:Detailed see specifications
Application:Pharm intermediate,New anti-advanced breast cancer drugs
PackAge:According to client's requirements
ProductionCapacity:1|Gram|Month
Storage:keep sealed and keep from direct light
Transportation:by sea/by air/by express

Superiority:

favourable price of 441045-17-6 High quality in bulk price

Eribulin Mesylate Basic information

Product Name: Eribulin Mesylate

Synonyms: Eribulin Mesylate;Halaven;Eribulin mesylate Halaven;Eribulin Mesilate

CAS: 441045-17-6

MF: C40H59NO11.CH4O3S

MW: 0

EINECS: 813-106-4

Product Categories: -

Mol File: Mol File

Eribulin Mesylate Structure

Eribulin Mesylate Chemical Properties

Safety Information

MSDS Information

Eribulin Mesylate Usage And Synthesis

Definition ChEBI: A methanesulfonate salt obtained by reaction of eribulin with one equivalent of methanesulfonic acid. A fully synthetic macrocyclic ketone analogue of marine sponge natural products. Inhibits growth phase of microtubules via tubulin-based antimitotic mecha ism, which leads to G2/M cell-cycle block, disruption of mitotic spindles, and, ultimately, apoptotic cell death after prolonged mitotic blockage.

Product Name：

Eribulin mesylate

Assay：

99.0%

Cas No.：

441045-17-6

New anti-advanced breast cancer drugs

Details:

Hangzhou ZeErRui Chemical Co., Ltd. is focused on customization, research and development and production of APIs and advanced intermediates, which can effectively compensate for the deficiencies of traditional CRO and CMO. Priority of high-tech barriers, high value-added, low pollution characteristics of the project, landing the project of innovative non patented route design, difficult process development and rapid industrialization. Starting from the advantages of combining technology research and stable production, Lead Biotech cooperated with domestic and foreign large pharmaceutical companies in the development of generic drugs and innovative drugs.

It also has hardware facilities and support teams that match the strength of R & D and production: With LCMS, HPLC and other perfect detection means, professional testing team and perfect quality control system; With a pilot base, a stable GMP standard production capacity, and a new GMP workshop is building; With regular financial, legal ERP system and professional sales and logistics team.